Review: anti-influenza viral effects of camellia tea
by P.G. Tharindu; I.D.U.H. Piyathilake; E.P.N. Udayakumara
International Journal of Agriculture Innovation, Technology and Globalisation (IJAITG), Vol. 3, No. 2, 2023

Abstract: Influenza virus cause 3-5 million severe medical cases, including nearly 500,000 respiratory deaths globally annually. Even with vaccines and antiviral drugs, it always manages to re-emerge. In traditional medicine, Camellia sinensis tea is used as a remedy and prevention against Influenza. This article researched previous literature rigorously to analyse the anti-influenza viral effects of camellia tea, experimental designs, gaps in previous work and limitations of employed approaches. In literature, epigallocatechin gallate (EGCG) and theaflavin digallate (TF3) in camellia tea had shown prominent anti-viral properties against influenza. Clinical approach, in-vitro and social survey were commonly used approaches while majority were clinical approaches. Surveys were least used. The accuracy of the in-vitro was highest, while social surveys being least accurate. We further noticed that the exact mechanisms, pharmacokinetics, pharmacodynamics and toxicology of these compounds as independent or as mixtures in the real human body are not yet fully known.

Online publication date: Tue, 28-Nov-2023

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Agriculture Innovation, Technology and Globalisation (IJAITG):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com